Display options
Share it on

J Cachexia Sarcopenia Muscle. 2011 Sep;2(3):135-142. doi: 10.1007/s13539-011-0038-2. Epub 2011 Aug 24.

Cardio-renal cachexia syndromes (CRCS): pathophysiological foundations of a vicious pathological circle.

Journal of cachexia, sarcopenia and muscle

Mariantonietta Cicoira, Stefan D Anker, Claudio Ronco

PMID: 21966640 PMCID: PMC3177036 DOI: 10.1007/s13539-011-0038-2

Abstract

Cardio-renal syndromes (CRS) are defined as disorders of the heart and kidney whereby acute or chronic dysfunction in one organ may induce acute or chronic dysfunction of the other. CRS have been classified into five categories, where types 2 and 4 represent respectively chronic cardio-renal and chronic reno-cardiac syndromes. In these conditions, the chronic disorder of either the heart or kidney has been shown to induce some degree of cachexia. At the same time, cachexia has been proposed as a possible mechanism contributing to the worsening of such pathological organ cross talk. Common pathogenetic mechanisms underlie body wasting in cachectic states of different chronic heart and kidney diseases. In these circumstances, a vicious circle could arise, in which cachexia associated with either heart failure or chronic kidney disease may contribute to further damage of the other organ. In chronic CRS, activation of the immune and neuroendocrine systems contributes to the genesis of cachexia, which in turn can negatively affect the heart and kidney function. In patients with cardiac sustained activation of the immune and neuroendocrine systems and oxidative stress, renal vascular resistance can increase and therefore impair renal perfusion, leading to worsening kidney function. Similarly, in renal cachexia, increased levels of pro-inflammatory cytokines can cause progressive left ventricular systolic dysfunction, myocardial cell death, endothelial dysfunction and increased myocardial fibrosis, with consequent impairment of the chronic reno-cardiac syndrome type 4. Thus, we speculate that the occurrence of different types of chronic CRS could represent a fundamental step in the genesis of cachexia, being renal and cardiac dysfunction closely related to the occurrence of systemic disorders leading to a final common pathway. Therefore, the heart and kidney and cachexia represent a triad causing a vicious circle that increases mortality and morbidity: In such circumstances, we may plausibly talk about cardio-renal cachexia syndrome. Complex interrelations may explain the transition from CRS to cachexia and from cachexia to CRS. Identification of the exact mechanisms occurring in these conditions could potentially help in preventing and treating this deadly combination.

References

  1. Ren Fail. 2005;27(2):171-5 - PubMed
  2. J Am Coll Cardiol. 2008 Apr 1;51(13):1268-74 - PubMed
  3. J Am Coll Cardiol. 2009 Feb 17;53(7):589-596 - PubMed
  4. Semin Dial. 2000 Jul-Aug;13(4):252-5 - PubMed
  5. Heart Fail Rev. 2012 Mar;17(2):211-20 - PubMed
  6. Am J Kidney Dis. 1998 Nov;32(5 Suppl 3):S112-9 - PubMed
  7. J Am Soc Nephrol. 2003 Apr;14(4):1022-30 - PubMed
  8. Am J Clin Nutr. 2006 Apr;83(4):735-43 - PubMed
  9. J Clin Endocrinol Metab. 2001 Dec;86(12):5992 - PubMed
  10. J Am Soc Nephrol. 2002 Nov;13(11):2748-52 - PubMed
  11. ASAIO J. 1996 Sep-Oct;42(5):M911-5 - PubMed
  12. J Ren Nutr. 2010 Nov;20(6):414-8 - PubMed
  13. Circ Res. 1993 Jul;73(1):205-9 - PubMed
  14. Endocrinology. 2007 Jun;148(6):3004-12 - PubMed
  15. J Am Coll Cardiol. 2008 Nov 4;52(19):1527-39 - PubMed
  16. Shock. 2001 Sep;16(3):189-95 - PubMed
  17. Clin J Am Soc Nephrol. 2006 Jan;1(1):8-18 - PubMed
  18. J Am Soc Nephrol. 2006 Jul;17(7):2034-47 - PubMed
  19. Cytokine. 2001 Jul 21;15(2):80-6 - PubMed
  20. Nature. 1999 Dec 9;402(6762):656-60 - PubMed
  21. Circulation. 2006 Feb 7;113(5):671-8 - PubMed
  22. Adv Chronic Kidney Dis. 2009 Nov;16(6):501-10 - PubMed
  23. Semin Dial. 2007 Nov-Dec;20(6):566-9 - PubMed
  24. Circulation. 2008 Jan 29;117(4):e25-146 - PubMed
  25. N Engl J Med. 2004 Sep 23;351(13):1296-305 - PubMed
  26. Heart Fail Rev. 2010 Nov;15(6):543-62 - PubMed
  27. J Am Soc Nephrol. 2007 Apr;18(4):1307-15 - PubMed
  28. Circ Heart Fail. 2008 May;1(1):25-33 - PubMed
  29. Intensive Care Med. 2008 May;34(5):957-62 - PubMed
  30. Circulation. 1997 Jul 15;96(2):526-34 - PubMed
  31. J Am Coll Cardiol. 2003 Mar 5;41(5):725-8 - PubMed
  32. J Am Coll Cardiol. 2005 Sep 20;46(6):1019-26 - PubMed
  33. Nutr Rev. 1994 Oct;52(10):340-7 - PubMed
  34. J Cachexia Sarcopenia Muscle. 2010 Sep;1(1):7-8 - PubMed
  35. J Ren Nutr. 2009 Jan;19(1):20-4 - PubMed
  36. Crit Care Med. 1999 Sep;27(9):1775-80 - PubMed
  37. Circulation. 2010 Feb 23;121(7):e46-e215 - PubMed
  38. J Am Coll Cardiol. 1997 Dec;30(7):1758-64 - PubMed
  39. Curr Opin Clin Nutr Metab Care. 2002 May;5(3):237-9 - PubMed
  40. Br Heart J. 1994 Aug;72(2 Suppl):S36-9 - PubMed
  41. J Ren Nutr. 2007 Jan;17(1):13-6 - PubMed
  42. Ann Surg. 2007 Mar;245(3):480-6 - PubMed
  43. Am J Clin Nutr. 2004 Aug;80(2):299-307 - PubMed
  44. J Ren Nutr. 2010 Sep;20(5):281-292, 7 p following 292 - PubMed
  45. J Nutr. 1999 Jan;129(1S Suppl):247S-251S - PubMed
  46. Crit Care Med. 2006 Feb;34(2):344-53 - PubMed
  47. Curr Opin Clin Nutr Metab Care. 2008 Sep;11(5):632-9 - PubMed
  48. Circulation. 2000 Dec 19;102(25):3060-7 - PubMed
  49. Nephrol Dial Transplant. 2004 Aug;19(8):2095-100 - PubMed
  50. Clin Nutr. 2008 Dec;27(6):793-9 - PubMed
  51. Physiol Rev. 2009 Apr;89(2):381-410 - PubMed
  52. Circ Res. 1997 Aug;81(2):187-95 - PubMed
  53. Pediatr Nephrol. 2006 Dec;21(12):1807-14 - PubMed
  54. J Am Soc Nephrol. 2007 Feb;18(2):629-36 - PubMed
  55. J Clin Invest. 1996 Dec 15;98(12):2854-65 - PubMed
  56. Circulation. 1989 Aug;80(2):299-305 - PubMed
  57. Eur Heart J. 2006 Mar;27(5):569-81 - PubMed
  58. Am J Kidney Dis. 2003 Nov;42(5):864-81 - PubMed
  59. Science. 1992 Jul 17;257(5068):387-9 - PubMed
  60. Br Heart J. 1993 Aug;70(2):141-3 - PubMed
  61. Arch Intern Med. 2004 Mar 22;164(6):659-63 - PubMed
  62. Arch Intern Med. 1985 Jul;145(7):1278-81 - PubMed
  63. J Mol Cell Cardiol. 1997 Mar;29(3):859-70 - PubMed
  64. Cytokine. 2005 Dec 7;32(5):234-9 - PubMed
  65. Lancet. 1997 Apr 12;349(9058):1050-3 - PubMed
  66. Blood Purif. 2010;29(2):105-10 - PubMed
  67. Eur Heart J. 1997 Feb;18(2):259-69 - PubMed
  68. J Natl Cancer Inst. 1997 Dec 3;89(23):1763-73 - PubMed
  69. Circulation. 1998 Apr 14;97(14):1382-91 - PubMed
  70. J Am Coll Cardiol. 2004 Oct 19;44(8):1593-600 - PubMed
  71. Hemodial Int. 2006 Oct;10(4):315-25 - PubMed
  72. Ann Med. 1997 Aug;29(4):339-43 - PubMed
  73. Eur Heart J. 1999 May;20(9):683-93 - PubMed
  74. Lancet. 2003 Mar 29;361(9363):1077-83 - PubMed
  75. J Card Fail. 2007 Aug;13(6):422-30 - PubMed
  76. Am J Cardiol. 1997 Apr 15;79(8):1128-31 - PubMed
  77. Kidney Int. 2007 Jan;71(2):146-52 - PubMed
  78. J Am Soc Nephrol. 2003 Jun;14(6):1549-58 - PubMed
  79. J Am Coll Cardiol. 2008 Apr 15;51(15):1419-28 - PubMed
  80. QJM. 1998 Mar;91(3):199-203 - PubMed
  81. N Engl J Med. 1990 Jul 26;323(4):236-41 - PubMed
  82. Circulation. 1996 Feb 15;93(4):704-11 - PubMed
  83. J Ren Nutr. 2006 Jul;16(3):208-11 - PubMed
  84. Circulation. 2001 Oct 23;104(17):2034-8 - PubMed
  85. Diabetes. 2001 Nov;50(11):2540-7 - PubMed
  86. J Card Fail. 2003 Jun;9(3):219-26 - PubMed
  87. Am J Cardiol. 1989 Mar 15;63(11):709-13 - PubMed
  88. Semin Nephrol. 2006 Mar;26(2):105-13 - PubMed
  89. Eur J Heart Fail. 2007 Oct;9(10):1064-9 - PubMed
  90. J Am Coll Cardiol. 2009 Feb 17;53(7):557-573 - PubMed
  91. Am J Cardiol. 1996 Jun 1;77(14):1250-2 - PubMed
  92. J Am Coll Cardiol. 2001 Jun 15;37(8):2080-5 - PubMed
  93. Kidney Int Suppl. 2003 May;(84):S162-7 - PubMed
  94. Clin Endocrinol (Oxf). 2008 Sep;69(3):347-58 - PubMed
  95. Blood Purif. 2011;31(1-3):70-6 - PubMed
  96. Heart Fail Rev. 2001 Mar;6(2):95-103 - PubMed
  97. Nephrol Dial Transplant. 2009 Aug;24(8):2421-8 - PubMed
  98. Nephrol Dial Transplant. 1996 Jul;11(7):1277-85 - PubMed
  99. Lancet. 1999 May 29;353(9167):1838-42 - PubMed

Publication Types